Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2017) | Total Docs. (3years) | Total Refs. (2017) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2017) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Pharmacology and Therapeutics | journal | 4.072 Q1 | 233 | 142 | 357 | 25171 | 3990 | 356 | 10.55 | 177.26 |  |
| 2 | Drug Metabolism Reviews | journal | 1.271 Q1 | 108 | 21 | 98 | 3158 | 491 | 97 | 4.10 | 150.38 | |
| 3 | Drug Resistance Updates | journal | 3.986 Q1 | 132 | 17 | 62 | 2472 | 756 | 62 | 12.40 | 145.41 | |
| 4 | Expert Opinion on Emerging Drugs | journal | 1.109 Q1 | 54 | 28 | 129 | 3050 | 393 | 121 | 3.39 | 108.93 |  |
| 5 | Neurotherapeutics | journal | 2.530 Q1 | 136 | 97 | 234 | 8875 | 1420 | 216 | 5.60 | 91.49 |  |
| 6 | Cochrane Database of Systematic Reviews | journal | 2.347 Q1 | 327 | 1348 | 4691 | 122482 | 22768 | 4653 | 4.44 | 90.86 | |
| 7 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 46 | 5 | 70 | 447 | 173 | 70 | 2.58 | 89.40 | | |
| 8 | Expert Review of Neurotherapeutics | journal | 1.006 Q2 | 98 | 118 | 398 | 10360 | 1250 | 373 | 3.25 | 87.80 | |
| 9 | Journal of Cardiovascular Development and Disease | journal | 32 | 22 | 70 | 1902 | 107 | 65 | 1.75 | 86.45 |  | |
| 10 | Expert Opinion on Orphan Drugs | journal | 0.279 Q3 | 27 | 97 | 383 | 8193 | 251 | 371 | 0.75 | 84.46 | |
| 11 | CNS Drugs | journal | 1.635 Q1 | 129 | 85 | 261 | 6852 | 1259 | 256 | 4.63 | 80.61 | |
| 12 | Expert Review of Clinical Pharmacology | journal | 0.833 Q2 | 60 | 127 | 314 | 10221 | 816 | 296 | 2.50 | 80.48 | |
| 13 | Expert Opinion on Investigational Drugs | journal | 1.166 Q1 | 117 | 137 | 398 | 10419 | 1361 | 387 | 3.58 | 76.05 | |
| 14 | Vaccines | journal | 1.691 Q1 | 85 | 51 | 141 | 3816 | 745 | 137 | 5.54 | 74.82 | |
| 15 | Drugs | journal | 1.547 Q1 | 188 | 163 | 472 | 11786 | 2433 | 463 | 5.16 | 72.31 | |
| 16 | PPAR Research | journal | 1.204 Q1 | 59 | 25 | 85 | 1798 | 273 | 83 | 3.46 | 71.92 | |
| 17 | Expert Opinion on Drug Safety | journal | 1.112 Q1 | 90 | 139 | 510 | 9936 | 1737 | 490 | 3.31 | 71.48 | |
| 18 | Journal of Biomedical Science | journal | 1.302 Q1 | 110 | 95 | 289 | 6787 | 1043 | 289 | 3.55 | 71.44 | |
| 19 | Expert Opinion on Pharmacotherapy | journal | 0.909 Q2 | 93 | 207 | 732 | 14623 | 2161 | 707 | 3.10 | 70.64 | |
| 20 | Expert Review of Anticancer Therapy | journal | 0.804 Q2 | 85 | 120 | 430 | 8365 | 856 | 403 | 2.10 | 69.71 | |
| 21 | Journal of International Peacekeeping | journal | 0.158 Q4 | 14 | 10 | 51 | 682 | 7 | 49 | 0.09 | 68.20 | |
| 22 | BioDrugs | journal | 1.038 Q2 | 79 | 45 | 131 | 3062 | 513 | 125 | 4.40 | 68.04 | |
| 23 | Journal of Psychopharmacology | journal | 1.939 Q1 | 135 | 158 | 402 | 10619 | 1715 | 374 | 4.59 | 67.21 | |
| 24 | PharmaNutrition | journal | 0.418 Q3 | 30 | 18 | 64 | 1139 | 109 | 61 | 1.81 | 63.28 | |
| 25 | Targeted Oncology | journal | 1.304 Q1 | 59 | 76 | 169 | 4792 | 572 | 165 | 3.69 | 63.05 |  |
| 26 | Frontiers in Pharmacology | journal | 1.587 Q1 | 154 | 939 | 1090 | 58981 | 4637 | 1025 | 3.85 | 62.81 | |
| 27 | Therapeutic Advances in Infectious Disease | journal | 1.065 Q2 | 29 | 15 | 25 | 926 | 138 | 23 | 7.07 | 61.73 | |
| 28 | Current Treatment Options in Oncology | journal | 1.240 Q1 | 66 | 75 | 176 | 4616 | 666 | 176 | 4.00 | 61.55 | |
| 29 | Side Effects of Drugs Annual | book series | 0.103 Q4 | 9 | 49 | 206 | 3005 | 11 | 0 | 0.10 | 61.33 | |
| 30 | Therapeutic Advances in Vaccines and Immunotherapy | journal | 13 | 4 | 0 | 241 | 0 | 0 | 0.00 | 60.25 | | |
| 31 | Methods in Pharmacology and Toxicology | book series | 0.120 Q4 | 14 | 35 | 252 | 2076 | 71 | 120 | 0.30 | 59.31 | |
| 32 | Drugs and Aging | journal | 1.072 Q2 | 109 | 87 | 273 | 5126 | 806 | 263 | 2.66 | 58.92 | |
| 33 | Journal des Anti-Infectieux | journal | 0.107 Q4 | 6 | 16 | 81 | 938 | 6 | 78 | 0.04 | 58.63 | |
| 34 | Antibiotics | journal | 1.063 Q2 | 77 | 39 | 116 | 2276 | 357 | 112 | 2.84 | 58.36 | |
| 35 | International Journal of Neuropsychopharmacology | journal | 1.808 Q1 | 125 | 111 | 514 | 6468 | 2277 | 502 | 4.50 | 58.27 | |
| 36 | Paediatric Drugs | journal | 0.814 Q2 | 70 | 58 | 143 | 3378 | 372 | 136 | 2.41 | 58.24 | |
| 37 | Journal of Pharmaceutical Health Care and Sciences | journal | 10 | 1 | 31 | 58 | 30 | 30 | 0.97 | 58.00 | | |
| 38 | European Neuropsychopharmacology | journal | 1.911 Q1 | 130 | 124 | 619 | 7137 | 2622 | 600 | 4.12 | 57.56 | |
| 39 | Current Cardiovascular Risk Reports | journal | 0.515 Q3 | 34 | 37 | 155 | 2124 | 155 | 155 | 1.01 | 57.41 | |
| 40 | Clinical Pharmacokinetics | journal | 1.482 Q1 | 184 | 122 | 301 | 6990 | 1370 | 272 | 4.16 | 57.30 | |
| 41 | Inflammopharmacology | journal | 0.925 Q2 | 68 | 59 | 111 | 3377 | 353 | 105 | 3.33 | 57.24 | |
| 42 | Primary Care - Clinics in Office Practice | journal | 0.590 Q2 | 59 | 68 | 181 | 3839 | 277 | 147 | 1.76 | 56.46 | |
| 43 | Journal of Experimental Pharmacology | journal | 0.981 Q2 | 23 | 9 | 13 | 501 | 27 | 13 | 1.92 | 55.67 |  |
| 44 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.272 Q1 | 57 | 64 | 175 | 3550 | 510 | 169 | 2.61 | 55.47 | |
| 45 | American Journal of Cardiovascular Drugs | journal | 0.951 Q2 | 60 | 47 | 128 | 2530 | 376 | 121 | 2.88 | 53.83 | |
| 46 | Cardiovascular Drugs and Therapy | journal | 1.349 Q1 | 79 | 62 | 204 | 3322 | 537 | 172 | 2.67 | 53.58 | |
| 47 | Experimental and Clinical Psychopharmacology | journal | 1.176 Q1 | 101 | 57 | 162 | 3054 | 430 | 160 | 2.58 | 53.58 | |
| 48 | npj Vaccines | journal | 2.269 Q1 | 47 | 34 | 16 | 1814 | 46 | 15 | 2.88 | 53.35 | |
| 49 | OpenNano | journal | 0.192 Q3 | 21 | 8 | 4 | 408 | 2 | 4 | 0.50 | 51.00 | |
| 50 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.738 Q2 | 61 | 63 | 278 | 3202 | 478 | 265 | 1.67 | 50.83 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data